Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
about
Immune modulation during latent herpesvirus infectionEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesThe long and evolving relationship between viruses and multiple sclerosisThe role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants.CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyEpstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisGenetic and infectious profiles of Japanese multiple sclerosis patients.Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisRisk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic reviewVitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.Gut microbiota, immunity, and disease: a complex relationship.Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis.The effect of smoking on the symptoms and progression of multiple sclerosis: a review.Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.The initiation and prevention of multiple sclerosis.Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, IranNo association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS.The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosisImmune characteristics study of AG490, a signal pathway inhibitor, in EAE model miceAnalysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset.Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.Clinical biomarkers in multiple sclerosis.The emerging agenda of stratified medicine in neurology.Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.Serostatus of Epstein-Barr virus in Iranian MS patients.The influence of sodium on pathophysiology of multiple sclerosis.Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis.Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV.Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
P2860
Q24624044-36BC38FD-8954-4924-B2D9-DFBA45885E91Q26830464-65180932-C085-4D59-87D1-0FDFDC3BBD6CQ26866256-4D71FA0C-7AC7-482A-8A22-9A78AEFB3674Q29301310-85D9DD5E-8481-419B-AFC7-4155228A283EQ30452682-CDD1BA43-9AA6-4F2C-95D9-A5D56D330EF9Q30834276-CA5E22BF-58C2-4D2F-8F91-DC4D8C61E5A9Q30878158-4649FBC2-ECDA-4EF6-A9DC-DE06D1D3D6C9Q33599648-A703B315-63C0-4EBB-AE90-584E3FA210D9Q33687084-B83B7FC4-43B7-4D34-80EB-E94FD70BCFA9Q33764503-3D7088B3-AC6F-4AA2-850E-5AC4E686A0E9Q34477393-7E8D8AF7-BD84-4897-944B-6F9E82B0ED8EQ34515198-25383EFF-4F02-4C68-AFB8-9F8EAA2C4686Q34671815-872DD4D9-1C60-4ADD-86F1-1AA9CDDC0C73Q35087429-78FF113E-6A21-433C-A2D3-50ADB32FDE6FQ35098876-626DFEF6-4775-4E44-A1A8-09C3AFECAED6Q35195785-C577563F-C95F-489F-99C1-6C20B3D71980Q35211150-5976ECF7-041F-467B-AF52-87DF5074C030Q35557367-B58C0E5E-A54C-4639-82A5-58D94C98DFE1Q35674246-DE9D164F-103F-4C63-B2F6-9B623E195A52Q35697927-7898379D-0B8E-4C9C-9944-D12EE7B0E9DAQ35741861-F48D298C-722C-407B-BF2A-EEEC4CED03DEQ35993313-1C952342-D796-4D41-A8BE-52CD50C92CD9Q36300076-B7257A5E-00A2-41AA-8141-136338E69F5AQ36339988-81D6703F-C9E2-4D4F-93A2-403D2FD58069Q36396476-122DBBCC-E659-4A3F-83E6-842B95B89357Q36451667-79807AFE-2816-47CC-BD63-47426EEE526FQ37151141-FC1CEEEF-F4BF-4EA8-96FE-CED44318453FQ37610907-40431815-6DFD-4163-ACAE-B4CD1D46525CQ37644275-D6CE2B2B-5DF0-45E3-8E02-83E9F4271DE0Q37956299-78D7CAF1-00ED-43D2-8540-A821A2EA3F8CQ37963472-6EB08565-F7B0-452C-801E-AB42C3189686Q38018052-45457C4D-4D75-46C4-B9A1-AC7B8149BC4BQ38088728-E0E43C37-6810-411E-89DD-3EE5F9D65343Q38169977-6F0E337D-C4F3-4FBB-91F3-262830EE9CBEQ38517180-0CE87D88-4026-44B1-A6CC-72AE50EB087BQ38996008-88C94DEF-6A9F-40A9-B28A-E20B952AA49BQ39081430-07C29D2A-6131-47E2-A641-226EC6FC90BEQ40050869-DFA3B67C-B4C9-4060-9298-6F5DD3D219CCQ40098267-FE3F5BC7-9F98-433F-88EA-93AF0A6E375FQ40113533-91407F07-2ABD-4D49-B802-BB7241D5ACD1
P2860
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Humoral immune response to EBV ...... with disease activity on MRI.
@ast
Humoral immune response to EBV ...... with disease activity on MRI.
@en
type
label
Humoral immune response to EBV ...... with disease activity on MRI.
@ast
Humoral immune response to EBV ...... with disease activity on MRI.
@en
prefLabel
Humoral immune response to EBV ...... with disease activity on MRI.
@ast
Humoral immune response to EBV ...... with disease activity on MRI.
@en
P2093
P2860
P1433
P1476
Humoral immune response to EBV ...... with disease activity on MRI.
@en
P2093
D H Miller
K Schmierer
R A Farrell
Z Khaleeli
P2860
P356
10.1212/WNL.0B013E3181AA29FE
P407
P577
2009-05-20T00:00:00Z